Capricor Therapeutics Inc
NASDAQ:CAPR

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
NASDAQ:CAPR
Watchlist
Price: 18.71 USD 1.19% Market Closed
Market Cap: 608.8m USD
Have any thoughts about
Capricor Therapeutics Inc?
Write Note

Capricor Therapeutics Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Capricor Therapeutics Inc
Net Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Capricor Therapeutics Inc
NASDAQ:CAPR
Net Income
-$28m
CAGR 3-Years
-16%
CAGR 5-Years
-19%
CAGR 10-Years
-13%
Abbvie Inc
NYSE:ABBV
Net Income
$5.4B
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Net Income
-$384m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Income
$3.1B
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
-5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income
-$489.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
4%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income
$4.3B
CAGR 3-Years
-11%
CAGR 5-Years
16%
CAGR 10-Years
27%

See Also

What is Capricor Therapeutics Inc's Net Income?
Net Income
-28m USD

Based on the financial report for Jun 30, 2024, Capricor Therapeutics Inc's Net Income amounts to -28m USD.

What is Capricor Therapeutics Inc's Net Income growth rate?
Net Income CAGR 10Y
-13%

Over the last year, the Net Income growth was 4%. The average annual Net Income growth rates for Capricor Therapeutics Inc have been -16% over the past three years , -19% over the past five years , and -13% over the past ten years .

Back to Top